Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05652725 · ClinicalTrials.gov registry record · NA

Radicle Clarity: A Study of Health and Wellness Products on Mental Clarity and Health Outcomes

A NA study of Cognitive Function, sponsored by Radicle Science.

Completed
Registry status
NA
Development phase
4,826
Enrollment target
1
Study location

NCT05652725: Completed NA study of Cognitive Function, sponsored by Radicle Science.

NCT05652725 is a NA study of Cognitive Function that has completed, run by Radicle Science. The registered enrollment target is 4,826 participants, above the 256-participant average among 20 other Cognitive Function trials with a reported enrollment target (1785% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05652725, a NA study of Cognitive Function, has completed, sponsored by Radicle Science.

COMPLETED
Registry status
NA
Development phase
4,826 participants
Enrollment target
1
Study location

Study Summary

A randomized, blinded, placebo-controlled direct-to-consumer study of health and wellness products on mental clarity and other health outcomes

Primary Outcome

Mean difference in cognition score as assessed by Patient Reported Outcome Measurement System (PROMIS) Cognitive Function Short Form 8A (scale 8-40; where the higher scores correspond to greater cognitive function)

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Clarity Active Study Product 1.1 Usage
  • DIETARY_SUPPLEMENT Clarity Active Study Product 2.1 Usage
  • DIETARY_SUPPLEMENT Clarity Active Study Product 3.1 Usage
  • DIETARY_SUPPLEMENT Clarity Active Study Product 4.1 Usage
  • DIETARY_SUPPLEMENT Clarity Active Study Product 4.2 Usage

Study Locations (1)

California

  • Radicle Science, Inc - Del Mar

Trial Details

FieldValue
Enrollment Target 4,826 participants
Start Date 2023-01-09
Est. Completion 2024-04-24
Phase NA
Radicle Science

55 total trials

What the finished NCT05652725 record still lists

NCT05652725 is an interventional study that assigns participants to a tested intervention. Its 4,826 participants enrollment target places it among the larger protocols in the corpus, above the 256-participant average among 20 other Cognitive Function trials with a reported enrollment target (1785% higher).

The record links to 1 condition, with Cognitive Function appearing as the primary indexed condition, and to 5 interventions - of which Clarity Active Study Product 1.1 Usage is the first listed.

NCT05652725 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05652725 about?

NCT05652725 is a clinical study titled "Radicle Clarity: A Study of Health and Wellness Products on Mental Clarity and Health Outcomes". A randomized, blinded, placebo-controlled direct-to-consumer study of health and wellness products on mental clarity and other health outcomes

What is the current status of trial NCT05652725?

This trial is currently completed. It is a NA study. The enrollment target is 4,826 participants. The study started on 2023-01-09. Estimated completion is 2024-04-24.

What conditions does trial NCT05652725 study?

This clinical trial studies the following conditions: Cognitive Function.

What interventions are being tested in trial NCT05652725?

The interventions under investigation include: Clarity Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Clarity Active Study Product 2.1 Usage (DIETARY_SUPPLEMENT), Clarity Active Study Product 3.1 Usage (DIETARY_SUPPLEMENT), Clarity Active Study Product 4.1 Usage (DIETARY_SUPPLEMENT), Clarity Active Study Product 4.2 Usage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05652725?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05652725 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05652725's enrollment target sits among peer trials

4,826 1st of 20 higher than 20 of 20 other Cognitive Function trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Function trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01719055 · 4,800 participants

    RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

  • NCT05485675 · 4,800 participants · NA

    Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program

  • NCT06307652 · 4,800 participants · Phase 3

    Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • NCT05252754 · 4,874 participants · Phase 3

    Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05652725, the US trial registry maintained by the National Library of Medicine. NCT05652725 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.